title: Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication.
abstract: The influenza A virus nucleoprotein (NP) is a multifunctional polypeptide which plays a pivotal role in virus replication. To get information on the domains and specific residues involved in the different NP activities, we describe here the preparation and characterization of 20 influenza A virus mutant NPs. The mutations, mostly single-amino-acid substitutions, were introduced in a cDNA copy of the A/Victoria/3/75 NP gene and, in most cases, affected residues located in regions that were highly conserved across the NPs of influenza A, B, and C viruses. The mutant NPs were characterized (i) in vivo (cell culture) by analyzing their intracellular localization and their functionality in replication, transcription, and expression of model RNA templates; and (ii) in vitro by analyzing their RNA-binding and sedimentation properties. The results obtained allowed us to identify both a mutant protein that accumulated in the cytoplasm and mutations that altered the functionality and/or the oligomerization state of the NP polypeptide. Among the mutations that reduced the NP capability to express chloramphenicol acetyltransferase protein from a model viral RNA (vRNA) template, some displayed a temperature-sensitive phenotype. Interestingly, four mutant NPs, which showed a reduced functionality in synthesizing cRNA molecules from a vRNA template, were fully competent to reconstitute complementary ribonucleoproteins (cRNPs) capable of synthesizing vRNAs, which in turn yielded mRNA molecules. Based on the phenotype of these mutants and on previously published observations, it is proposed that these mutant NPs have a reduced capability to interact with the polymerase complex and that this NP-polymerase interaction is responsible for making vRNPs switch from mRNA to cRNA synthesis.
authors.affiliation: Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III, Majadahonda 28220, Madrid, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Mena
authors.forename: E
authors.initials: E
authors.lastname: Jambrina
authors.forename: C
authors.initials: C
authors.lastname: Albo
authors.forename: B
authors.initials: B
authors.lastname: Perales
authors.forename: J
authors.initials: J
authors.lastname: Ortín
authors.forename: M
authors.initials: M
authors.lastname: Arrese
authors.forename: D
authors.initials: D
authors.lastname: Vallejo
authors.forename: A
authors.initials: A
authors.lastname: Portela
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D019556:COS Cells; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D015870:Gene Expression; D006801:Humans; D009980:Influenza A virus / Q000235:genetics* / Q000378:metabolism; D007424:Intracellular Fluid; D008969:Molecular Sequence Data; D016296:Mutagenesis; D019590:Nucleocapsid Proteins; D009698:Nucleoproteins / Q000235:genetics* / Q000378:metabolism; D012367:RNA, Viral / Q000096:biosynthesis* / Q000378:metabolism; D016601:RNA-Binding Proteins; D014758:Viral Core Proteins / Q000235:genetics* / Q000378:metabolism
chemical_list: C048842:NP protein, Influenza A virus; D019590:Nucleocapsid Proteins; D009698:Nucleoproteins; D012367:RNA, Viral; D016601:RNA-Binding Proteins; D014758:Viral Core Proteins; D015500:Chloramphenicol O-Acetyltransferase